Biodesix (BDSX) Net Income towards Common Stockholders (2019 - 2026)
Biodesix (BDSX) posted Net Income towards Common Stockholders of -$8.2 million for Q1 2026, down 103.13% quarter-over-quarter from -$4.0 million in Q4 2025, and up 24.42% year-on-year from -$6.6 million in Q1 2025.
Biodesix (BDSX) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has reported Net Income towards Common Stockholders for 8 consecutive years, with -$8.2 million the latest figure, recorded in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$8.2 million, up 24.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$32.9 million (up 17.69% YoY), and the FY2025 annual result was -$35.6 million, up 16.76% from the prior year.
- Net Income towards Common Stockholders was -$8.2 million for Q1 2026 at Biodesix, down from -$4.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$4.0 million in Q4 2025 and troughed at -$18.8 million in Q1 2023.
- Average Net Income towards Common Stockholders over 5 years is -$11.5 million, with a median of -$10.8 million recorded in 2025.
- Year-over-year, Net Income towards Common Stockholders tumbled 150.21% in 2022 and jumped 52.08% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$16.4 million in 2022, then soared by 44.05% to -$9.2 million in 2023, then increased by 8.67% to -$8.4 million in 2024, then surged by 52.08% to -$4.0 million in 2025, then slumped by 103.13% to -$8.2 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$8.2 million in Q1 2026, -$4.0 million in Q4 2025, and -$9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Biodesix | 236.57 Mn | 211.00 Mn | 21.35 Mn | -8.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.18 Mn |
| Dec 31, 2025 | -4.03 Mn |
| Sep 30, 2025 | -9.13 Mn |
| Jun 30, 2025 | -11.62 Mn |
| Mar 31, 2025 | -10.82 Mn |
| Dec 31, 2024 | -8.40 Mn |
| Sep 30, 2024 | -10.63 Mn |
| Jun 30, 2024 | -10.17 Mn |
| Mar 31, 2024 | -13.55 Mn |
| Dec 31, 2023 | -9.20 Mn |
| Sep 30, 2023 | -9.56 Mn |
| Jun 30, 2023 | -13.36 Mn |
| Mar 31, 2023 | -18.76 Mn |
| Dec 31, 2022 | -16.44 Mn |
| Sep 30, 2022 | -13.65 Mn |
| Jun 30, 2022 | -12.97 Mn |
| Mar 31, 2022 | -15.60 Mn |
| Dec 31, 2021 | -13.18 Mn |
| Sep 30, 2021 | -14.64 Mn |
| Jun 30, 2021 | -11.40 Mn |